Cauley J, Lui L, LeBoff M, Watts N
J Clin Endocrinol Metab. 2024; 110(1):e1-e7.
PMID: 39403961
PMC: 11651675.
DOI: 10.1210/clinem/dgae726.
Bigelow E, Goulet R, Ciarelli A, Schlecht S, Kohn D, Bredbenner T
JBMR Plus. 2022; 6(8):e10653.
PMID: 35991534
PMC: 9382868.
DOI: 10.1002/jbm4.10653.
Jepsen K, Bigelow E, Ramcharan M, Schlecht S, Karvonen-Gutierrez C
Womens Midlife Health. 2016; 2.
PMID: 27672442
PMC: 5035036.
DOI: 10.1186/s40695-016-0016-0.
Fenton A
J Midlife Health. 2016; 6(4):147-53.
PMID: 26903753
PMC: 4743275.
DOI: 10.4103/0976-7800.172292.
Faubion S, Kuhle C, Shuster L, Rocca W
Climacteric. 2015; 18(4):483-91.
PMID: 25845383
PMC: 4581591.
DOI: 10.3109/13697137.2015.1020484.
Bone status in cystic fibrosis.
Sood M, Hambleton G, Super M, Fraser W, Adams J, Mughal M
Arch Dis Child. 2001; 84(6):516-20.
PMID: 11369574
PMC: 1718803.
DOI: 10.1136/adc.84.6.516.
Population screening for osteoporosis to prevent fractures.
Sheldon T, Freemantle N, Ibbotson S, Pollock C, Mason J, Long A
Qual Health Care. 1992; 1(1):77-80.
PMID: 10136838
PMC: 1056814.
DOI: 10.1136/qshc.1.1.77.
Fast and slow bone losers. Relevance to the management of osteoporosis.
Hough S
Drugs Aging. 1998; 12 Suppl 1:1-7.
PMID: 9673860
DOI: 10.2165/00002512-199812001-00001.
Bone mineral density in female junior, senior and former football players.
Duppe H, Gardsell P, Johnell O, Ornstein E
Osteoporos Int. 1996; 6(6):437-41.
PMID: 9116388
DOI: 10.1007/BF01629575.
Bone density and shape as determinants of bone strength in IGF-I and/or pamidronate-treated ovariectomized rats.
Ammann P, Rizzoli R, Meyer J, Bonjour J
Osteoporos Int. 1996; 6(3):219-27.
PMID: 8783296
DOI: 10.1007/BF01622738.
Recommendations for the registration of new chemical entities used in the prevention and treatment of osteoporosis.
Reginster J, Compston J, Jones E, Kaufman J, Audran M, Bouvenot G
Calcif Tissue Int. 1995; 57(4):247-50.
PMID: 8673859
DOI: 10.1007/BF00298877.
Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures.
Marshall D, Johnell O, Wedel H
BMJ. 1996; 312(7041):1254-9.
PMID: 8634613
PMC: 2351094.
DOI: 10.1136/bmj.312.7041.1254.
Is bone mineral density advantage maintained long-term in previous weight lifters?.
Karlsson M, Johnell O, Obrant K
Calcif Tissue Int. 1995; 57(5):325-8.
PMID: 8564793
DOI: 10.1007/BF00302066.
Bone mineral density in weight lifters.
Karlsson M, Johnell O, Obrant K
Calcif Tissue Int. 1993; 52(3):212-5.
PMID: 8481835
DOI: 10.1007/BF00298721.
Screening for osteoporosis by bone densitometry: a stratified intervention approach.
Prince R, Geelhoed E, Harris T, Hockey R, Price R, Smith M
Osteoporos Int. 1993; 3 Suppl 1:75-7.
PMID: 8461584
DOI: 10.1007/BF01621871.
Determinants of peak bone mass in young adult women: a review.
Anderson J, Tylavsky F, Halioua L, Metz J
Osteoporos Int. 1993; 3 Suppl 1:32-6.
PMID: 8461572
DOI: 10.1007/BF01621858.
When bone mass fails to predict bone failure.
Ott S
Calcif Tissue Int. 1993; 53 Suppl 1:S7-13.
PMID: 8275383
DOI: 10.1007/BF01673395.
Bone mass and beyond: risk factors for fractures.
Ross P, Davis J, Wasnich R
Calcif Tissue Int. 1993; 53 Suppl 1:S134-7; discussion S137-8.
PMID: 8275367
DOI: 10.1007/BF01673422.
Individuals who sustain nonosteoporotic fractures continue to also sustain fragility fractures.
Karlsson M, Hasserius R, Obrant K
Calcif Tissue Int. 1993; 53(4):229-31.
PMID: 8275349
DOI: 10.1007/BF01320906.
The effects of 2-year treatment with the aminobisphosphonate alendronate on bone metabolism, bone histomorphometry, and bone strength in ovariectomized nonhuman primates.
Balena R, Toolan B, Shea M, Markatos A, Myers E, Lee S
J Clin Invest. 1993; 92(6):2577-86.
PMID: 8254015
PMC: 288453.
DOI: 10.1172/JCI116872.